UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Braun Stacey Associates Inc.

Braun Stacey Associates Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,983 shares of the healthcare conglomerate’s stock after selling 4,958 shares during the quarter. Braun Stacey Associates Inc.’s holdings in UnitedHealth Group were worth $20,732,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group in the third quarter valued at approximately $37,000. DecisionPoint Financial LLC boosted its holdings in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after acquiring an additional 62 shares during the period. Highline Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $55,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group in the third quarter valued at $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on UNH. Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Finally, Wells Fargo & Company dropped their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Down 1.4 %

Shares of NYSE:UNH opened at $523.48 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company’s 50-day moving average price is $523.11 and its two-hundred day moving average price is $563.00. The stock has a market capitalization of $481.75 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the company posted $5.83 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.